Literature DB >> 36171405

Letter-to-the-Editor: Two-Stage Expander-Based (EB) or Single-Stage Direct-to-Implant (DTI) Breast Reconstruction-An Ongoing Debate.

Bishara Atiyeh1, Saif Emsieh2.   

Abstract

Entities:  

Year:  2022        PMID： 36171405     DOI： 10.1007/s00266-022-03113-0

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN： 0364-216X            Impact factor:   2.708


× No keyword cloud information.
  10 in total

1.  Higher reconstruction failure and less patient-reported satisfaction after post mastectomy radiotherapy with immediate implant-based breast reconstruction compared to immediate autologous breast reconstruction.

Authors:  F C J Reinders; D A Young-Afat; M C T Batenburg; S E Bruekers; E A van Amerongen; J F M Macaré van Maurik; A Braakenburg; E Zonnevylle; M Hoefkens; T Teunis; H M Verkooijen; H J G D van den Bongard; W Maarse
Journal:  Breast Cancer       Date:  2019-12-19       Impact factor: 4.239

2.  Comparative study of patient outcomes between direct to implant and two-stage implant-based breast reconstruction after mastectomy.

Authors:  Glenda Giorgia Caputo; Enrico Vigato; Emanuele Rampino Cordaro; Pier Camillo Parodi; Maurizio Governa
Journal:  J Plast Reconstr Aesthet Surg       Date:  2021-03-30       Impact factor: 2.740

3.  Long-term Patient-Reported Outcomes in Postmastectomy Breast Reconstruction.

Authors:  Katherine B Santosa; Ji Qi; Hyungjin M Kim; Jennifer B Hamill; Edwin G Wilkins; Andrea L Pusic
Journal:  JAMA Surg       Date:  2018-10-01       Impact factor: 14.766

4.  Long-term Patient-reported Outcomes Following Postmastectomy Breast Reconstruction: An 8-year Examination of 3268 Patients.

Authors:  Jonas A Nelson; Robert J Allen; Thais Polanco; Meghana Shamsunder; Aadit R Patel; Colleen M McCarthy; Evan Matros; Joseph H Dayan; Joseph J Disa; Peter G Cordeiro; Babak J Mehrara; Andrea L Pusic
Journal:  Ann Surg       Date:  2019-09       Impact factor: 12.969

Review 5.  Is Single-Stage Prosthetic Reconstruction Cost Effective? A Cost-Utility Analysis for the Use of Direct-to-Implant Breast Reconstruction Relative to Expander-Implant Reconstruction in Postmastectomy Patients.

Authors:  Naveen M Krishnan; John P Fischer; Marten N Basta; Maurice Y Nahabedian
Journal:  Plast Reconstr Surg       Date:  2016-09       Impact factor: 4.730

6.  A descriptive comparison of satisfaction and well-being between expander-based and direct-to-implant breast reconstruction after Nipple-Sparing Mastectomy.

Authors:  Egidio Riggio; Sara Alfieri; Elisa Toffoli; Claudia Borreani
Journal:  Aesthetic Plast Surg       Date:  2022-08-26       Impact factor: 2.708

7.  Application of allogeneic sclera combined with tarso-conjunctival flap in total excision of divided eyelid nevus.

Authors:  Junping Li; Yuhong Wang; Dongping Li; Na Zhou; Anshi Du; Xiaolin Qin; Jianbin Hu
Journal:  J Plast Reconstr Aesthet Surg       Date:  2022-06-18       Impact factor: 3.022

8.  Matched Preliminary Analysis of Patient-Reported Outcomes following Autologous and Implant-Based Breast Reconstruction.

Authors:  Jonas A Nelson; Meghana G Shamsunder; Paige L Myers; Thais O Polanco; Michelle R Coriddi; Colleen M McCarthy; Evan Matros; Joseph H Dayan; Joseph J Disa; Babak J Mehrara; Andrea L Pusic; Robert J Allen
Journal:  Ann Surg Oncol       Date:  2022-04-03       Impact factor: 4.339

9.  Skin sparing/skin reducing mastectomy (SSM/SRM) and the concept of oncoplastic breast surgery.

Authors:  Bishara Atiyeh; Saad Dibo; Elias Zgheib; Jaber Abbas
Journal:  Int J Surg       Date:  2014-08-29       Impact factor: 6.071

10.  Single Stage Direct-to-Implant Breast Reconstruction Has Lower Complication Rates Than Tissue Expander and Implant and Comparable Rates to Autologous Reconstruction in Patients Receiving Postmastectomy Radiation.

Authors:  George E Naoum; Laura Salama; Andrzej Niemierko; Bruno Lavajo Vieira; Yazid Belkacemi; Amy S Colwell; Jonathan Winograd; Barbara Smith; Alice Ho; Alphonse G Taghian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-11-19       Impact factor: 7.038
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.